FDA — authorised 31 July 1984
- Application: ANDA088368
- Marketing authorisation holder: HOSPIRA
- Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Lignospan Forte on 31 July 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 31 July 1984; FDA authorised it on 31 July 1984; FDA authorised it on 31 July 1984.
HOSPIRA holds the US marketing authorisation.